Positive Diabetes Prevention Study Helps Raise Provention Bio Shares By Over 300% In A Day
An experimental medicine developed by a New Jersey-based drug company – Provention Bio, appeared to postpone the onset of type 1 diabetes in a clinical trial which pushed the shares of the company, which listed itself on the share market last year, more than tripped on the news. According to the results of the clinical…









